Prodotto aggiunto correttamente al carrello.

(11β)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
Visualizzare in 3D

Indagoo logo

(11β)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione

CAS: 126784-99-4

Rif. AN-AG003AC7

1g
Fuori produzione
10mg
Fuori produzione
50mg
Fuori produzione
100mg
Fuori produzione
250mg
Fuori produzione

Prodotto fuori produzione. Per informazioni su prodotti simili, compilare il nostro modulo di richiesta o inviarci un'e-mail a .


Informazioni sul prodotto

Nome:
(11β)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
Sinonimi:
  • [u'(11beta)-17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione', u'Ella norpregnadiene', u'Esmya', u'ulipristal acetate', u'Ulipristal acetate', u'126784-99-4', u'Ella', u'EllaOne', u'Ulipristal (acetate)', u'CDB-2914', u'Ulipristal acetate(CDB2914)', u'CDB 2914', u'UNII-YF7V70N02B', u'VA2914', u'YF7V70N02B', u'CHEBI:71025', u'17-Acetoxy-11-(4-N,N-dimethylaminophenyl)pregna-4,9-diene-3,20-dione', u'C30H37NO4', u'CBD 2914', u'(11beta)-17-(Acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione', u'(11beta)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione', u'(11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-yl acetate', u'17beta-acetyl-11beta-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17alpha-yl acetate', u'(8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate', u'[(8S,11R,13S,14S,17R)-17-acetyl-11-(4-dimethylaminophenyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate', u'Ulipristal acetate [USAN]', u'Hrp-2000', u'Ulipristal acet', u'4oar', u'Ulipristal-Acetate', u'EllaOne|||Esmya', u'RTI 3021-012', u'AC1L2Y8A', u'SCHEMBL544957', u'CHEMBL260538', u'GTPL7460', u'Ulipristal acetate (JAN/USAN)', u'DTXSID30155294', u'OOLLAFOLCSJHRE-ZHAKMVSLSA-N', u'[(8s,11r,13s,14s,17r)-17-Acetyl-11-[4-(Dimethylamino)phenyl]-13-Methyl-3-Oxo-1,2,6,7,8,11,12,14,15,16-Decahydrocyclopenta[a]phenanthren-17-Yl] Acetate', u'AMX10180', u'ZINC3920657', u'BDBM50375424', u'MFCD00899035', u'Ulipristal acetate, >=98% (HPLC)', u'AKOS026750526', u'CS-1157', u'KS-00000Z24', u'NCGC00378913-02', u'HY-16508', u'SC-44720', u'FT-0675731', u'U0102', u'X4788', u'D09687', u'EN300-220766', u'W-5201', u'AB01566874_01', u'784A994', u'J-005436', u'BRD-K64381438-001-03-8', u'Z2216208644', u'19-Norpregna-4,9-diene-3,20-dione,17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-, (11b)-', u'5-(Hydroxymethyl)-alpha,alpha,alpha,alpha-tetramethyl-1,3-benzenediacetonitrile', u'(10S,11S,14R,15S,17R)-14-acetyl-17-[4-(dimethylamino)phenyl]-15-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6-dien-14-yl acetate', u'(11alpha,13alpha,17beta)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-yl acetate', u'(11beta)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione / CDB-2914', u'19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-, (11beta)-', u'CBD 2914; VA 2914; (11b)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione', u'Ulipristal', u'Esmya', u'Ulipristal Actate', u'Ella (TN)', u'HRP 2000', u'VA 2914', u'C30-H37-N-O4', u'CID130904', u'RU 44675', u'ACN-037304', u'CS-O-10778', u'(11-beta)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione', u'17-alpha-acetoxy-11-beta-(4-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione', u'120511-88-8']
  • (11Beta,17Alpha)-17-Acetyl-11-[4-(Dimethylamino)Phenyl]-3-Oxoestra-4,9-Dien-17-Yl Acetate
  • 17-Acetoxy-11β-[(4-(N,N-dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
  • 17-Acetoxy-11β-[(4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
  • 17-Acetyloxy-11β-[(4-(N,N-dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
  • 17α-Acetoxy-11β-(4-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione
  • 17α-Acetoxy-11β-[4-N,N-dimethylaminophenyl]-19-norpregna-4,9-diene-3,20-dione
  • 19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-, (11β)-
  • Cbd(Va) 2914
  • Cdb-2914
  • Vedi altri sinonimi
  • EllaOne
  • Esmya
  • Hrp 2000
  • Rti-3021-012
  • Ru 44675
  • Ulipristal Acetate
  • Ulipristal,Ella
  • Va 2914
Marchio:
Indagoo
Conservazione lunga:
Note:

Proprietà chimiche

Peso molecolare:
475.6191
Formula:
C30H37NO4
Purezza:
98%
Colore/Forma:
Solid
InChI:
InChI=1S/C30H37NO4/c1-18(32)30(35-19(2)33)15-14-27-25-12-8-21-16-23(34)11-13-24(21)28(25)26(17-29(27,30)3)20-6-9-22(10-7-20)31(4)5/h6-7,9-10,16,25-27H,8,11-15,17H2,1-5H3/t25-,26+,27-,29-,30-/m0/s1
InChI key:
OOLLAFOLCSJHRE-ZHAKMVSLSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta di informazioni sul prodotto fuori produzione: AN-AG003AC7 (11β)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".